The need for sub-total resection of the mandible (including lower border) or maxilla arises when a patient has an extensive tumour, cyst, or infection—such as osteosarcoma or massive cysts—requiring removal of most of the bone under anesthesia with assistance in a hospital to eradicate disease and preserve viable tissue. This procedure is indicated for severe pathology where a significant portion, but not all, of the jaw is affected, balancing complete removal with functional retention. It is critical in the maxillofacial region where extensive bone loss impacts speech, chewing, and facial support.
Specific scenarios include:
For example, a patient with a mandibular sarcoma might need this to remove most of the bone, with assistance aiding reconstruction. In aged care, an elderly patient with a massive maxillary cyst could require this to stop sinus issues, given their frailty. By resecting the affected portion, this service eliminates pathology, supports reconstruction, and preserves function, making it vital for extensive jaw disease in the maxillofacial area.
Surgeons performing a subtotal resection of the patient’s mandible or maxilla under anesthesia with assistance offer extensive benefits for severe conditions. A key advantage is removing extensive disease. This procedure eliminates the patient’s significant pathology, halting its impact—crucial for 'subtotal jaw resection benefits.' It also maintains some function by preserving portions of the jaw, supporting the patient’s basic oral capabilities. Additionally, it enables reconstruction by preparing the site for further repair, enhancing the patient’s recovery potential. For surgeons exploring 'maxillofacial subtotal resection advantages,' this assisted service ensures patients benefit from disease eradication, partial function retention, and reconstruction readiness, providing a balanced approach to advanced jaw conditions.
Recovery of 6-12 weeks with swelling and major diet changes; hospital stay required.
